PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
This Quarter Return
+35.14%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$2.02B
AUM Growth
+$2.02B
(+19%)
Cap. Flow
-$68.7M
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
71.4%
Holding
52
New
6
Increased
25
Reduced
3
Closed
6
Top Buys
| 1 |
THOR
THORATEC CORPORATION
THOR
|
$95.1M |
| 2 |
ENDP
Endo International plc
ENDP
|
$77.2M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$43.3M |
| 4 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
$42.6M |
| 5 |
Karyopharm Therapeutics
KPTI
|
$29.1M |
Top Sells
| 1 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
$169M |
| 2 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
$131M |
| 3 |
CYBX
CYBERONICS INC
CYBX
|
$77.7M |
| 4 |
NPSP
NPS PHARMACEUTICALS INC
NPSP
|
$42.6M |
| 5 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
$12.3M |
Sector Composition
| 1 | Healthcare | 70.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
United Therapeutics
UTHR
$13.8B
| $247M | 12.19% | 1,429,928 +26,800 | +2% | +$4.62M |
|
|
2
BioMarin Pharmaceuticals
BMRN
$11.2B
| $206M | 10.16% | 1,649,792 +347,595 | +27% | +$43.3M |
|
|
ANAC
3
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $189M | 9.32% | 3,259,045 +737,223 | +29% | +$42.6M |
|
|
ABMD
4
DELISTED
Abiomed Inc
ABMD
| $177M | 8.75% | 2,473,624 +13,500 | +0.5% | +$966K |
|
|
CLVS
5
DELISTED
Clovis Oncology, Inc.
CLVS
| $158M | 7.79% | 2,121,857 +19,000 | +0.9% | +$1.41M |
|
|
AMAG
6
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $120M | 5.91% | 2,187,041 +192,841 | +10% | +$10.5M |
|
|
THOR
7
DELISTED
THORATEC CORPORATION
THOR
| $106M | 5.26% | 2,538,203 +2,269,342 | +844% | +$95.1M |
|
8
Insmed
INSM
$28.8B
| $96.7M | 4.78% | 4,649,448 +23,800 | +0.5% | +$495K |
|
|
ENDP
9
DELISTED
Endo International plc
ENDP
| $77.2M | 3.81% | +860,204 | New | +$77.2M |
|
|
KYTH
10
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $69.3M | 3.43% | 1,382,722 +260,838 | +23% | +$13.1M |
|
|
WMGI
11
DELISTED
Wright Medical Group Inc
WMGI
| $52.9M | 2.61% | 2,049,251 +9,500 | +0.5% | +$245K |
|
|
SQNM
12
DELISTED
SEQUENOM INC NEW
SQNM
| $39.4M | 1.95% | 9,977,642 +51,900 | +0.5% | +$205K |
|
13
Vanda Pharmaceuticals
VNDA
$279M
| $35.4M | 1.75% | 3,803,408 +16,500 | +0.4% | +$153K |
|
|
14
Karyopharm Therapeutics
KPTI
$61.7M
| $29.1M | 1.44% | +951,032 | New | +$29.1M |
|
|
CELG
15
DELISTED
Celgene Corp
CELG
| $28.8M | 1.42% | 249,400 +33,900 | +16% | +$3.91M |
|
16
Gilead Sciences
GILD
$140B
| $28.6M | 1.41% | 291,000 +56,400 | +24% | +$5.53M |
|
|
EIGR
17
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $27.4M | 1.35% | 1,445,100 +41,300 | +3% | +$782K |
|
|
CYBX
18
DELISTED
CYBERONICS INC
CYBX
| $26.7M | 1.32% | 412,000 -1,196,101 | -74% | -$77.7M |
|
19
Prothena Corp
PRTA
$441M
| $26.5M | 1.31% | 695,918 +4,700 | +0.7% | +$179K |
|
|
SHPG
20
DELISTED
Shire pic
SHPG
| $22.7M | 1.12% | 95,000 +9,400 | +11% | +$2.25M |
|
|
MDVN
21
DELISTED
MEDIVATION, INC.
MDVN
| $22.2M | 1.1% | 171,700 +10,400 | +6% | +$1.34M |
|
|
MNTA
22
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $22.1M | 1.09% | 1,455,176 | – | – |
|
|
HTWR
23
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $21.4M | 1.06% | +243,868 | New | +$21.4M |
|
24
Amicus Therapeutics
FOLD
$2.34B
| $21.3M | 1.05% | 1,956,376 | – | – |
|
25
STAAR Surgical
STAA
$1.36B
| $19.6M | 0.97% | 2,642,922 +13,300 | +0.5% | +$98.8K |
|